Hypertriglyceridemia and lowered apolipoprotein C-II/C-III ratio in uremia: Effect of a fibric acid, clinofibrate
- 1 December 1993
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 44 (6), 1352-1359
- https://doi.org/10.1038/ki.1993.388
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Liver lipase and high-density lipoprotein lipoprotein changes after incubation of human serum with rat liver lipaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Insulin resistance in uremia mediated by postbinding defectsKidney International, 1982
- Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on HemodialysisNew England Journal of Medicine, 1979
- Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-IINew England Journal of Medicine, 1978
- Selective Deficiency of Hepatic Triglyceride Lipase in Uremic PatientsNew England Journal of Medicine, 1977
- Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant PatientsNew England Journal of Medicine, 1977
- Untoward Effects of Clofibrate in Hemodialyzed PatientsNew England Journal of Medicine, 1977
- Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoproteinBiochemical and Biophysical Research Communications, 1972
- A specific apoprotein activator for lipoprotein lipaseBiochemical and Biophysical Research Communications, 1970